Microbiology: Current Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Case Report - Microbiology: Current Research (2025) Volume 9, Issue 1

Emerging Infectious Diseases: The Role of Microbes in Global Health Crises

Lucas Edwards*

Department of Microbial Pathogenesis, Riverside Institute of Biological Sciences, United States

*Corresponding Author:
Lucas Edwards
Department of Microbial Pathogenesis
Riverside Institute of Biological Sciences, United States
E-mail: lucas.edwards@riversidebio.edu

Received: 09-Feb-2025, Manuscript No. AAMCR-25-161154; Editor assigned: 10-Feb-2025, PreQC No. AAMCR-25-161154 (PQ); Reviewed: 22-Feb-2025, QC No. AAMCR-25-161154; Revised: 24-Feb-2025, Manuscript No. AAMCR-25-161154 (R); Published: 28-Feb-2025, DOI: 10.35841/aamcr-9.1.247

Citation: Edwards L. Emerging Infectious Diseases: The Role of Microbes in Global Health Crises. J Micro Bio Curr Res. 2025;9(1):247

Visit for more related articles at Microbiology: Current Research

Introduction

Emerging infectious diseases (EIDs) are a significant global health challenge, driven by the complex interplay of microbial evolution, environmental changes, and human behavior. These diseases, caused by novel or previously controlled pathogens, pose severe risks to public health, often spreading rapidly across regions and leading to significant morbidity and mortality. The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, is a recent and powerful example of how an emerging infectious disease can overwhelm health systems, disrupt economies, and alter the social fabric of societies [1].

A multitude of factors contribute to the emergence of new infectious diseases, including microbial adaptation and mutation, human encroachment into wildlife habitats, urbanization, climate change, and increased global travel. Microbes, particularly viruses and bacteria, are constantly evolving. Their rapid mutation rates allow them to adapt to new hosts, escape immune responses, and develop resistance to existing treatments. Human activities, such as deforestation and agricultural expansion, increase contact between humans and wildlife, creating opportunities for zoonotic diseases—those transmitted from animals to humans—to emerge. Approximately 75% of EIDs are zoonotic in origin, including diseases like Ebola, HIV, and COVID-19 [2].

Viruses are the most frequent cause of EIDs due to their ability to mutate rapidly and cross species barriers. Influenza viruses, for example, undergo constant genetic shifts and drifts, leading to seasonal flu epidemics and occasional pandemics, such as the 1918 H1N1 influenza and the H5N1 avian flu outbreaks. Coronaviruses, responsible for severe acute respiratory syndrome (SARS) in 2003 and COVID-19 in 2019, have shown how novel viral pathogens can emerge from animal reservoirs, such as bats, and rapidly spread among human populations. The human immunodeficiency virus (HIV), which causes AIDS, emerged from primate populations in Central Africa and has since become a global pandemic, affecting millions worldwide [3].

Bacterial pathogens also play a significant role in EIDs, particularly due to the rise of antibiotic resistance. Diseases caused by drug-resistant bacteria, such as multidrug-resistant tuberculosis (MDR-TB), methicillin-resistant Staphylococcus aureus (MRSA), and carbapenem-resistant Enterobacteriaceae (CRE), are increasingly difficult to treat and contribute to global health crises. The overuse and misuse of antibiotics in human medicine and agriculture have accelerated the evolution of resistant strains, leading to the emergence of "superbugs" that defy current treatments [4].

Vector-borne diseases, transmitted by insects such as mosquitoes, ticks, and fleas, are another significant category of EIDs. Diseases like malaria, dengue fever, and Zika virus are spread by vectors that thrive in warm climates, and their prevalence is expected to increase with global warming. The Zika virus, which emerged in Brazil in 2015, caused widespread panic due to its association with severe birth defects, including microcephaly. Malaria and dengue fever, both transmitted by mosquitoes, remain persistent threats in tropical and subtropical regions, with malaria alone causing over 400,000 deaths annually [5].

Zoonotic diseases, or those that originate in animals, are among the most concerning EIDs due to their potential for rapid human transmission. The HIV/AIDS pandemic, which originated from non-human primates, is one of the most devastating examples of zoonotic spillover. Similarly, Ebola, which has caused multiple outbreaks in Central and West Africa, is believed to have originated in fruit bats and spreads to humans through contact with infected animals or their bodily fluids. The illegal wildlife trade, deforestation, and the consumption of bushmeat increase the likelihood of zoonotic spillover events, as humans encroach on natural habitats and come into contact with previously isolated animal populations [6].

Pandemics, the global spread of infectious diseases, have far-reaching consequences for both health systems and economies. The COVID-19 pandemic, which has infected over 200 million people and caused millions of deaths, disrupted economies worldwide, leading to significant losses in GDP, widespread unemployment, and a strain on healthcare infrastructure. Similarly, the 2009 H1N1 influenza pandemic and the 2014-2016 West African Ebola outbreak had profound economic and social impacts in affected regions. Pandemics often exacerbate existing inequalities, disproportionately affecting low-income and vulnerable populations with limited access to healthcare [7].

Effective public health surveillance is crucial for the early detection and containment of EIDs. Organizations like the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) play a critical role in monitoring outbreaks and coordinating global responses. The International Health Regulations (IHR) provide a legal framework for countries to report public health emergencies of international concern. However, challenges remain, particularly in low-resource settings where surveillance infrastructure is weak. Rapid diagnostics, real-time data sharing, and robust reporting systems are essential for improving the global response to emerging diseases [8].

Vaccines are among the most effective tools for preventing the spread of infectious diseases. The rapid development of COVID-19 vaccines was a scientific triumph, demonstrating the potential for vaccines to curb pandemics. However, access to vaccines remains unequal, with low- and middle-income countries often left behind in global vaccination campaigns. In addition to vaccines, antiviral and antibiotic therapies are essential for treating EIDs. The development of new therapeutics, including monoclonal antibodies and antivirals, has shown promise in combating viral diseases like Ebola and COVID-19 [9].

The fight against emerging infectious diseases requires global collaboration. No single country can tackle the threat of pandemics alone. International cooperation is essential for sharing resources, expertise, and data. Initiatives such as the Coalition for Epidemic Preparedness Innovations (CEPI) and Gavi, the Vaccine Alliance, aim to develop and distribute vaccines for EIDs, particularly in low-income countries. Global health security also depends on strengthening health systems, improving disease surveillance, and investing in research and development. The COVID-19 pandemic has shown that timely international collaboration can save lives, but it has also exposed weaknesses in the global health infrastructure that need to be addressed before the next pandemic strikes [10].

Conclusion

Emerging infectious diseases are an ever-present threat to global health, driven by microbial evolution, environmental changes, and human activities. Viruses, bacteria, and vector-borne pathogens are at the forefront of these crises, causing significant morbidity, mortality, and economic disruption. While advances in vaccines and therapeutics offer hope for controlling future outbreaks, the rise of antimicrobial resistance and zoonotic spillovers underscore the need for ongoing vigilance. Global collaboration, improved public health surveillance, and equitable access to healthcare are essential for mitigating the impact of future EIDs.

References

  1. Jones KE, Patel NG, Levy MA. Global trends in emerging infectious diseases. Nature. 2008;451(7181):990-3.

    2. Indexed at, Google Scholar, Cross Ref

  2. Morens DM, Folkers GK, Fauci AS. The challenge of emerging and re-emerging infectious diseases. Nature. 2004;430(6996):242-9.

    3. Indexed at, Google Scholar, Cross Ref

  3. Woolhouse ME, Haydon DT, Antia R. Emerging pathogens: the epidemiology and evolution of species jumps. Trends Ecol Evol. 2005;20(5):238-44.

    4. Indexed at, Google Scholar, Cross Ref

  4. Fauci AS, Morens DM. The perpetual challenge of infectious diseases. N Engl J Med. 2012;366(5):454-61.

    5. Indexed at, Google Scholar, Cross Ref

  5. Taubenberger JK, Morens DM. 1918 Influenza: the mother of all pandemics. Revista Biomedica. 2006;17(1):69-79.

    6. Indexed at, Google Scholar, Cross Ref

  6. Fan CY, Fann JC, Yang MC. Estimating global burden of COVID-19 with disability-adjusted life years and value of statistical life metrics. J Formos Med Assoc. 2021;120:S106-17.

    7. Indexed at, Google Scholar, Cross Ref

  7. Weaver SC, Costa F, Garcia-Blanco MA. Zika virus: History, emergence, biology, and prospects for control. Antivir Res. 2016;130:69-80.

    8. Indexed at, Google Scholar, Cross Ref

  8. Spellberg B, Guidos R, Gilbert D. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis. 2008;46(2):155-64.

    9. Indexed at, Google Scholar, Cross Ref

  9. Gubler DJ. Dengue, urbanization and globalization: the unholy trinity of the 21st century. Trop Med Int Health. 2011;39(4SUPPLEMENT):S3-11.

    10. Indexed at, Google Scholar, Cross Ref

  10. Lederberg J. Emerging infections: microbial threats to health. Trends Microbiol. 1993;1(2):43-4.

    11. Indexed at, Google Scholar, Cross Ref

Get the App